Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dancing | 5 | 2021 | 103 | 1.350 |
Why?
|
Gossypol | 6 | 2015 | 27 | 1.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2015 | 1369 | 0.760 |
Why?
|
Athletic Injuries | 6 | 2020 | 1140 | 0.690 |
Why?
|
Adolescent Development | 1 | 2020 | 283 | 0.620 |
Why?
|
Minocycline | 1 | 2015 | 162 | 0.510 |
Why?
|
Pancreatic Neoplasms | 5 | 2015 | 4981 | 0.410 |
Why?
|
Hallux | 2 | 2021 | 37 | 0.410 |
Why?
|
Mental Health | 1 | 2020 | 2682 | 0.310 |
Why?
|
Interleukins | 5 | 2015 | 797 | 0.290 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 458 | 0.280 |
Why?
|
Adenoviridae | 4 | 2015 | 1126 | 0.270 |
Why?
|
Sleep | 1 | 2020 | 4199 | 0.270 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1047 | 0.240 |
Why?
|
Gene Silencing | 1 | 2009 | 1606 | 0.230 |
Why?
|
Sesamoid Bones | 1 | 2021 | 13 | 0.220 |
Why?
|
Oncolytic Viruses | 2 | 2015 | 293 | 0.200 |
Why?
|
Basketball | 1 | 2021 | 47 | 0.200 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2824 | 0.200 |
Why?
|
Gene Transfer Techniques | 3 | 2014 | 1282 | 0.180 |
Why?
|
Soccer | 1 | 2021 | 121 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2015 | 3633 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 2946 | 0.180 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 174 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 11236 | 0.170 |
Why?
|
Sports Medicine | 1 | 2021 | 237 | 0.170 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13626 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6324 | 0.160 |
Why?
|
Running | 1 | 2021 | 459 | 0.150 |
Why?
|
Drug Design | 2 | 2012 | 1099 | 0.150 |
Why?
|
Tarsal Joints | 1 | 2015 | 30 | 0.140 |
Why?
|
Ovarian Neoplasms | 2 | 2009 | 4751 | 0.140 |
Why?
|
Cell Line, Tumor | 9 | 2015 | 16735 | 0.140 |
Why?
|
Receptor, EphA2 | 1 | 2015 | 44 | 0.140 |
Why?
|
Apoptosis | 5 | 2015 | 9971 | 0.140 |
Why?
|
Ankle Joint | 1 | 2019 | 376 | 0.140 |
Why?
|
Tarsal Bones | 1 | 2015 | 62 | 0.130 |
Why?
|
Nitrophenols | 1 | 2015 | 173 | 0.130 |
Why?
|
Muscle Strength | 1 | 2019 | 577 | 0.130 |
Why?
|
Range of Motion, Articular | 2 | 2019 | 1537 | 0.130 |
Why?
|
Tetracycline | 1 | 2015 | 219 | 0.130 |
Why?
|
Poly I-C | 1 | 2014 | 111 | 0.130 |
Why?
|
Foot Injuries | 1 | 2015 | 143 | 0.120 |
Why?
|
Drug Synergism | 2 | 2015 | 1853 | 0.120 |
Why?
|
Oncolytic Virotherapy | 2 | 2015 | 454 | 0.120 |
Why?
|
Mice, Nude | 6 | 2015 | 3801 | 0.110 |
Why?
|
Post-Concussion Syndrome | 1 | 2016 | 241 | 0.110 |
Why?
|
Syntenins | 1 | 2012 | 7 | 0.110 |
Why?
|
Hip Joint | 1 | 2019 | 950 | 0.110 |
Why?
|
Neoplasms | 4 | 2012 | 20528 | 0.100 |
Why?
|
Biphenyl Compounds | 1 | 2015 | 886 | 0.100 |
Why?
|
Knee Joint | 1 | 2019 | 1562 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 752 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2015 | 616 | 0.090 |
Why?
|
Receptors, Virus | 1 | 2012 | 671 | 0.080 |
Why?
|
Paclitaxel | 1 | 2015 | 1626 | 0.080 |
Why?
|
Animals | 14 | 2015 | 169404 | 0.080 |
Why?
|
Integrases | 1 | 2009 | 548 | 0.080 |
Why?
|
Prostatic Neoplasms | 3 | 2015 | 10605 | 0.080 |
Why?
|
Sulfonamides | 1 | 2015 | 1922 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4647 | 0.070 |
Why?
|
Genomic Instability | 1 | 2009 | 689 | 0.070 |
Why?
|
Motor Activity | 1 | 2016 | 2774 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8890 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2010 | 1203 | 0.070 |
Why?
|
Humans | 25 | 2021 | 715818 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1510 | 0.060 |
Why?
|
Mice | 8 | 2015 | 80373 | 0.060 |
Why?
|
Athletes | 2 | 2021 | 1051 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2015 | 5111 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8571 | 0.050 |
Why?
|
Adolescent | 5 | 2021 | 85157 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2007 | 944 | 0.050 |
Why?
|
Hip Injuries | 1 | 2020 | 77 | 0.050 |
Why?
|
Weight Lifting | 1 | 2020 | 133 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 3994 | 0.050 |
Why?
|
Cell Membrane | 1 | 2009 | 3881 | 0.050 |
Why?
|
Joints | 1 | 2020 | 336 | 0.040 |
Why?
|
Alleles | 1 | 2009 | 7099 | 0.040 |
Why?
|
Pelvic Bones | 1 | 2020 | 274 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2009 | 3636 | 0.040 |
Why?
|
Spinal Injuries | 1 | 2020 | 300 | 0.040 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2015 | 18 | 0.040 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2015 | 38 | 0.030 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2015 | 70 | 0.030 |
Why?
|
Knee Injuries | 1 | 2020 | 468 | 0.030 |
Why?
|
Protein Modification, Translational | 1 | 2014 | 22 | 0.030 |
Why?
|
Female | 11 | 2021 | 377229 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 6089 | 0.030 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 63 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 6035 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2015 | 396 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5250 | 0.030 |
Why?
|
Male | 11 | 2021 | 350352 | 0.030 |
Why?
|
Serotyping | 1 | 2014 | 377 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2210 | 0.030 |
Why?
|
RNA, Double-Stranded | 1 | 2014 | 271 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2015 | 333 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6592 | 0.030 |
Why?
|
Chemoprevention | 1 | 2014 | 316 | 0.030 |
Why?
|
Syndecans | 1 | 2012 | 80 | 0.030 |
Why?
|
Gelatinases | 1 | 2012 | 92 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 6009 | 0.030 |
Why?
|
Enzyme Precursors | 1 | 2012 | 182 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2015 | 556 | 0.030 |
Why?
|
Quinolones | 1 | 2015 | 400 | 0.030 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2012 | 128 | 0.030 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 146 | 0.030 |
Why?
|
Child | 4 | 2021 | 74468 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2015 | 14161 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2445 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1116 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1104 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1625 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 498 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1900 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2015 | 9849 | 0.020 |
Why?
|
Fracture Fixation, Internal | 1 | 2015 | 850 | 0.020 |
Why?
|
Transgenes | 1 | 2012 | 1014 | 0.020 |
Why?
|
Rats | 2 | 2015 | 24852 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2204 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 565 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18197 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56228 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2099 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 933 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 279 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2012 | 1323 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 314 | 0.020 |
Why?
|
Receptors, Peptide | 1 | 2007 | 268 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 1013 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2985 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6641 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10666 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3574 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2553 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2170 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1162 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3416 | 0.020 |
Why?
|
Piperazines | 1 | 2015 | 2524 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2007 | 830 | 0.020 |
Why?
|
Adult | 4 | 2020 | 212279 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6803 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 40887 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2699 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18787 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 11201 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12535 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 72473 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2883 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 34430 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 14912 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 70879 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 8047 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5198 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 62040 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 18591 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39305 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9809 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 51317 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 40032 | 0.010 |
Why?
|
United States | 1 | 2020 | 67910 | 0.010 |
Why?
|
Disease Progression | 1 | 2007 | 13215 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22663 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23729 | 0.010 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_